Oncology Small Molecule Drugs Market Report

Global and Region Oncology Small Molecule Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：137
  • REPORT CODE：GMM881241
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Oncology Small Molecule Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Oncology Small Molecule Drugsmarket, defines the market attractiveness level of Oncology Small Molecule Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Oncology Small Molecule Drugs industry, describes the types of Oncology Small Molecule Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Oncology Small Molecule Drugs market and the development prospects and opportunities of Oncology Small Molecule Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Oncology Small Molecule Drugs market in Chapter 13.

    By Player:

    • Company 1

    • Company 2

    • Company 3

    • Company 4

    • Company 5

    • Company 6

    • Company 7

    • Company 8

    • Company 9

    • Company 10

    By Type:

    • Chemotherapy Drugs

    • Immunomodulating Drugs

    • Targeted Therapy Drugs

    • Hormonal Therapy

    • Other

    By End-User:

    • Blood Cancer

    • Breast Cancer

    • Gastrointestinal Cancer

    • Prostate Cancer

    • Lung Cancer

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Oncology Small Molecule Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Oncology Small Molecule Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Oncology Small Molecule Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Oncology Small Molecule Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Oncology Small Molecule Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Oncology Small Molecule Drugs Consumption (2017-2022)

    • 7.2 United States Oncology Small Molecule Drugs Consumption (2017-2022)

    • 7.3 Europe Oncology Small Molecule Drugs Consumption (2017-2022)

    • 7.4 China Oncology Small Molecule Drugs Consumption (2017-2022)

    • 7.5 Japan Oncology Small Molecule Drugs Consumption (2017-2022)

    • 7.6 India Oncology Small Molecule Drugs Consumption (2017-2022)

    • 7.7 South Korea Oncology Small Molecule Drugs Consumption (2017-2022)

    8 Region and Country-wise Oncology Small Molecule Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Oncology Small Molecule Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Oncology Small Molecule Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Oncology Small Molecule Drugs Consumption Forecast (2022-2028)

    • 8.4 China Oncology Small Molecule Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Oncology Small Molecule Drugs Consumption Forecast (2022-2028)

    • 8.6 India Oncology Small Molecule Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Oncology Small Molecule Drugs Consumption Forecast (2022-2028)

    9 Global Oncology Small Molecule Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Oncology Small Molecule Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Chemotherapy Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Immunomodulating Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Targeted Therapy Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Hormonal Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Oncology Small Molecule Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Blood Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Breast Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Gastrointestinal Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Prostate Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Lung Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Oncology Small Molecule Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Oncology Small Molecule Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Chemotherapy Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Immunomodulating Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Targeted Therapy Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Oncology Small Molecule Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Gastrointestinal Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Oncology Small Molecule Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Oncology Small Molecule Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Oncology Small Molecule Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Oncology Small Molecule Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Oncology Small Molecule Drugs Market Competitive Analysis

    • 14.1 Company 1

      • 14.1.1 Company 1 Company Details

      • 14.1.2 Company 1 Oncology Small Molecule Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Company 1 Oncology Small Molecule Drugs Product and Service

    • 14.2 Company 2

      • 14.2.1 Company 2 Company Details

      • 14.2.2 Company 2 Oncology Small Molecule Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Company 2 Oncology Small Molecule Drugs Product and Service

    • 14.3 Company 3

      • 14.3.1 Company 3 Company Details

      • 14.3.2 Company 3 Oncology Small Molecule Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Company 3 Oncology Small Molecule Drugs Product and Service

    • 14.4 Company 4

      • 14.4.1 Company 4 Company Details

      • 14.4.2 Company 4 Oncology Small Molecule Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Company 4 Oncology Small Molecule Drugs Product and Service

    • 14.5 Company 5

      • 14.5.1 Company 5 Company Details

      • 14.5.2 Company 5 Oncology Small Molecule Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Company 5 Oncology Small Molecule Drugs Product and Service

    • 14.6 Company 6

      • 14.6.1 Company 6 Company Details

      • 14.6.2 Company 6 Oncology Small Molecule Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Company 6 Oncology Small Molecule Drugs Product and Service

    • 14.7 Company 7

      • 14.7.1 Company 7 Company Details

      • 14.7.2 Company 7 Oncology Small Molecule Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Company 7 Oncology Small Molecule Drugs Product and Service

    • 14.8 Company 8

      • 14.8.1 Company 8 Company Details

      • 14.8.2 Company 8 Oncology Small Molecule Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Company 8 Oncology Small Molecule Drugs Product and Service

    • 14.9 Company 9

      • 14.9.1 Company 9 Company Details

      • 14.9.2 Company 9 Oncology Small Molecule Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Company 9 Oncology Small Molecule Drugs Product and Service

    • 14.10 Company 10

      • 14.10.1 Company 10 Company Details

      • 14.10.2 Company 10 Oncology Small Molecule Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Company 10 Oncology Small Molecule Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Oncology Small Molecule Drugs

    • Figure Oncology Small Molecule Drugs Picture

    • Table Global Oncology Small Molecule Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Oncology Small Molecule Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Oncology Small Molecule Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Oncology Small Molecule Drugs Consumption by Country (2017-2022)

    • Figure United States Oncology Small Molecule Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Oncology Small Molecule Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Oncology Small Molecule Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Oncology Small Molecule Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Oncology Small Molecule Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Oncology Small Molecule Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Small Molecule Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Oncology Small Molecule Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Oncology Small Molecule Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Oncology Small Molecule Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Oncology Small Molecule Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Oncology Small Molecule Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Oncology Small Molecule Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Immunomodulating Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Targeted Therapy Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Hormonal Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Gastrointestinal Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunomodulating Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Targeted Therapy Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastrointestinal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Oncology Small Molecule Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Oncology Small Molecule Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Company 1 (Foundation Year, Company Profile and etc.)

    • Table Company 1 Oncology Small Molecule Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 1 Oncology Small Molecule Drugs Product and Service

    • Table Company 2 (Foundation Year, Company Profile and etc.)

    • Table Company 2 Oncology Small Molecule Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 2 Oncology Small Molecule Drugs Product and Service

    • Table Company 3 (Foundation Year, Company Profile and etc.)

    • Table Company 3 Oncology Small Molecule Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 3 Oncology Small Molecule Drugs Product and Service

    • Table Company 4 (Foundation Year, Company Profile and etc.)

    • Table Company 4 Oncology Small Molecule Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 4 Oncology Small Molecule Drugs Product and Service

    • Table Company 5 (Foundation Year, Company Profile and etc.)

    • Table Company 5 Oncology Small Molecule Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 5 Oncology Small Molecule Drugs Product and Service

    • Table Company 6 (Foundation Year, Company Profile and etc.)

    • Table Company 6 Oncology Small Molecule Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 6 Oncology Small Molecule Drugs Product and Service

    • Table Company 7 (Foundation Year, Company Profile and etc.)

    • Table Company 7 Oncology Small Molecule Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 7 Oncology Small Molecule Drugs Product and Service

    • Table Company 8 (Foundation Year, Company Profile and etc.)

    • Table Company 8 Oncology Small Molecule Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 8 Oncology Small Molecule Drugs Product and Service

    • Table Company 9 (Foundation Year, Company Profile and etc.)

    • Table Company 9 Oncology Small Molecule Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 9 Oncology Small Molecule Drugs Product and Service

    • Table Company 10 (Foundation Year, Company Profile and etc.)

    • Table Company 10 Oncology Small Molecule Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 10 Oncology Small Molecule Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US